Logo image of RELY

REMITLY GLOBAL INC (RELY) Stock Fundamental Analysis

NASDAQ:RELY - Nasdaq - US75960P1049 - Common Stock - Currency: USD

20.94  +0.67 (+3.31%)

After market: 21.27 +0.33 (+1.58%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to RELY. RELY was compared to 101 industry peers in the Financial Services industry. While RELY has a great health rating, there are worries on its profitability. RELY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year RELY has reported negative net income.
RELY had a positive operating cash flow in the past year.
In the past 5 years RELY always reported negative net income.
In the past 5 years RELY reported 4 times negative operating cash flow.
RELY Yearly Net Income VS EBIT VS OCF VS FCFRELY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

RELY has a Return On Assets of -3.65%. This is amonst the worse of the industry: RELY underperforms 86.14% of its industry peers.
With a Return On Equity value of -5.56%, RELY is not doing good in the industry: 80.20% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.65%
ROE -5.56%
ROIC N/A
ROA(3y)-10.47%
ROA(5y)-9.32%
ROE(3y)-17.19%
ROE(5y)-15.62%
ROIC(3y)N/A
ROIC(5y)N/A
RELY Yearly ROA, ROE, ROICRELY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

RELY has a better Gross Margin (65.85%) than 80.20% of its industry peers.
In the last couple of years the Gross Margin of RELY has grown nicely.
RELY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.19%
GM growth 5Y3.35%
RELY Yearly Profit, Operating, Gross MarginsRELY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

8

2. Health

2.1 Basic Checks

RELY does not have a ROIC to compare to the WACC, probably because it is not profitable.
RELY has more shares outstanding than it did 1 year ago.
The number of shares outstanding for RELY has been increased compared to 5 years ago.
The debt/assets ratio for RELY has been reduced compared to a year ago.
RELY Yearly Shares OutstandingRELY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
RELY Yearly Total Debt VS Total AssetsRELY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

RELY has an Altman-Z score of 8.09. This indicates that RELY is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of RELY (8.09) is better than 93.07% of its industry peers.
The Debt to FCF ratio of RELY is 0.01, which is an excellent value as it means it would take RELY, only 0.01 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.01, RELY belongs to the best of the industry, outperforming 91.09% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that RELY is not too dependend on debt financing.
RELY has a better Debt to Equity ratio (0.00) than 91.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 8.09
ROIC/WACCN/A
WACC15.73%
RELY Yearly LT Debt VS Equity VS FCFRELY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

RELY has a Current Ratio of 2.73. This indicates that RELY is financially healthy and has no problem in meeting its short term obligations.
RELY has a better Current ratio (2.73) than 85.15% of its industry peers.
RELY has a Quick Ratio of 2.73. This indicates that RELY is financially healthy and has no problem in meeting its short term obligations.
RELY has a better Quick ratio (2.73) than 86.14% of its industry peers.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 2.73
RELY Yearly Current Assets VS Current LiabilitesRELY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 71.21% over the past year.
The Revenue has grown by 33.86% in the past year. This is a very strong growth!
Measured over the past years, RELY shows a very strong growth in Revenue. The Revenue has been growing by 58.44% on average per year.
EPS 1Y (TTM)71.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.21%
Revenue 1Y (TTM)33.86%
Revenue growth 3Y40.21%
Revenue growth 5Y58.44%
Sales Q2Q%32.91%

3.2 Future

RELY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 90.87% yearly.
The Revenue is expected to grow by 19.22% on average over the next years. This is quite good.
EPS Next Y115.34%
EPS Next 2Y87.58%
EPS Next 3Y75.83%
EPS Next 5Y90.87%
Revenue Next Year25.7%
Revenue Next 2Y23.14%
Revenue Next 3Y20.85%
Revenue Next 5Y19.22%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RELY Yearly Revenue VS EstimatesRELY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
RELY Yearly EPS VS EstimatesRELY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 1.5 2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RELY. In the last year negative earnings were reported.
RELY is valuated quite expensively with a Price/Forward Earnings ratio of 718.57.
Based on the Price/Forward Earnings ratio, RELY is valued a bit more expensive than 77.23% of the companies in the same industry.
RELY's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.86.
Industry RankSector Rank
PE N/A
Fwd PE 718.57
RELY Price Earnings VS Forward Price EarningsRELY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as RELY.
Industry RankSector Rank
P/FCF 23.76
EV/EBITDA N/A
RELY Per share dataRELY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RELY does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as RELY's earnings are expected to grow with 75.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y87.58%
EPS Next 3Y75.83%

More info and screens

0

5. Dividend

5.1 Amount

RELY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REMITLY GLOBAL INC

NASDAQ:RELY (5/2/2025, 8:20:44 PM)

After market: 21.27 +0.33 (+1.58%)

20.94

+0.67 (+3.31%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners82.16%
Inst Owner Change-0.48%
Ins Owners5.48%
Ins Owner Change-0.89%
Market Cap4.27B
Analysts82.22
Price Target27.53 (31.47%)
Short Float %3.67%
Short Ratio2.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)89.63%
Min EPS beat(2)66.06%
Max EPS beat(2)113.2%
EPS beat(4)4
Avg EPS beat(4)60.53%
Min EPS beat(4)25.26%
Max EPS beat(4)113.2%
EPS beat(8)7
Avg EPS beat(8)33.94%
EPS beat(12)8
Avg EPS beat(12)13.61%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.67%
Min Revenue beat(2)0.48%
Max Revenue beat(2)2.86%
Revenue beat(4)2
Avg Revenue beat(4)-0.22%
Min Revenue beat(4)-3.7%
Max Revenue beat(4)2.86%
Revenue beat(8)4
Avg Revenue beat(8)0.67%
Revenue beat(12)7
Avg Revenue beat(12)1.1%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-13.98%
PT rev (3m)11.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)32.53%
EPS NY rev (1m)0%
EPS NY rev (3m)195.23%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)-0.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 718.57
P/S 3.32
P/FCF 23.76
P/OCF 21.6
P/B 6.31
P/tB 7
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)0.03
Fwd EY0.14%
FCF(TTM)0.88
FCFY4.21%
OCF(TTM)0.97
OCFY4.63%
SpS6.3
BVpS3.32
TBVpS2.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.65%
ROE -5.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.85%
FCFM 13.99%
ROA(3y)-10.47%
ROA(5y)-9.32%
ROE(3y)-17.19%
ROE(5y)-15.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.19%
GM growth 5Y3.35%
F-Score7
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA N/A
Cap/Depr 98.05%
Cap/Sales 1.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 2.73
Altman-Z 8.09
F-Score7
WACC15.73%
ROIC/WACCN/A
Cap/Depr(3y)90.84%
Cap/Depr(5y)93.25%
Cap/Sales(3y)1.15%
Cap/Sales(5y)1.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.21%
EPS Next Y115.34%
EPS Next 2Y87.58%
EPS Next 3Y75.83%
EPS Next 5Y90.87%
Revenue 1Y (TTM)33.86%
Revenue growth 3Y40.21%
Revenue growth 5Y58.44%
Sales Q2Q%32.91%
Revenue Next Year25.7%
Revenue Next 2Y23.14%
Revenue Next 3Y20.85%
Revenue Next 5Y19.22%
EBIT growth 1Y65.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year435.88%
EBIT Next 3Y99.3%
EBIT Next 5Y80.95%
FCF growth 1Y381.98%
FCF growth 3YN/A
FCF growth 5Y170.09%
OCF growth 1Y462.91%
OCF growth 3YN/A
OCF growth 5Y87.29%